Rik Derynck

Rik Derynck

Company: University of California San Francisco

Job title: Professor - Departments of Cell, Tissue Biology & Anatomy


Panel Discussion: Debating the Best Approach to Target TGF-ß 10:45 am

• Which TGF-ß isoform to target to maximize therapeutic potential in IO and minimize adverse risk • Combination approaches vs monotherapy? • Is there one therapeutic approach with greater potential than others?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.